EC detains 11.5M life sciences products for IP violations; Sanofi is working on fixes to French vax plant;

> The European Commission Customs Union seized 11.5 million medicines and medical products for suspected violations of intellectual property in 2009. Article

> Sanofi Pasteur CEO Wayne Pisano has responded to a July letter from the FDA by saying the vaccine maker has already addressed, or is currently addressing, microbial contamination and other manufacturing shortcomings at a plant in France. Article

> Specialty pharma Global Health Ventures has signed an agreement with Canadian CMO Carter Pharmaceutical to manufacture 10,000 pills of the sublingual formulation for anti-anxiety drug Relax-B for testing. Release

> Green Planet Bioengineering has received a patent for the "sync effective" extraction process it uses in making Salvia Miltiorrhiza for use in health supplements and prescription drugs. Release

> Romanian pharma distributor Relad has begun dynamic routing after adopting ORTEC's Transport and Distribution solution. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.